LC
ALBO

Lindbrook Capital’s Albireo Pharma Inc ALBO Stock Holding History

Lindbrook Capital’s Portfolio ALBO Stock Details ALBO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-416
Closed -$8.99K – 2964
2022
Q4 		$8.99K Sell
416
-290
-41% -$6.13K ﹤0.01% 1492
2022
Q3 		$14K Buy
706
+672
+1,976% +$13.9K ﹤0.01% 1189
2022
Q2 		$1K Buy
34
+15
+79% +$396 ﹤0.01% 2443
2022
Q1 		$1K Buy
+19
New +$556 ﹤0.01% 2440
2020
Q3 		– Sell
-112
Closed -$3K – 1878
2020
Q2 		$3K Buy
+112
New +$2.64K ﹤0.01% 1323

Other funds holding ALBO

DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Lindbrook Capital's ALBO Position: Q1 2023 in Review

Lindbrook Capital sold out of Albireo Pharma Inc (ALBO) in Q1 2023, closing a stake of 416 shares — an estimated $8.99K sold.

Lindbrook Capital first reported a position in ALBO in Q2 2020 and held it in 5 quarters. The position peaked at $14K in Q3 2022. 3 funds tracked by Wall St. Rank hold ALBO as of Q1 2023.

  • Lindbrook Capital reported no remaining Albireo Pharma Inc position as of Q1 2023 after selling out during the quarter.
  • Lindbrook Capital sold 416 Albireo Pharma Inc shares in Q1 2023, an estimated $8.99K.
  • Lindbrook Capital first reported a position in Albireo Pharma Inc in Q2 2020 and held it in 5 quarters.
  • Lindbrook Capital's Albireo Pharma Inc position peaked at $14K in Q3 2022.
  • 3 funds tracked by Wall St. Rank held Albireo Pharma Inc as of Q1 2023.

Based on Lindbrook Capital's 13F filing for Q1 2023, filed 26 Apr 2023.